New Report Reveals Big Gaps in 340B Oversight
Do you ever wonder how big tax-exempt hospitals are able to get away with marking up medications and profiting from the 340B program? The short answer: a lack of federal oversight and accountability.
An eye-opening new report from ADVI Health reveals just how broken the 340B auditing and oversight process is. Inadequate oversight allows hospitals and clinics to profit from 340B, freely mark up the cost of care, and raise costs for all of us.
This report is an important reminder that the first step to fix 340B is demanding stronger transparency and oversight. Together, we will continue to push for a more accountable program.